All lobbying filings

Bluebird Strategies

Bluebird Strategies filed a Q4 report for Myotonic on January 21, 2026.

Lobbying for Myotonic · Patient advocacy organization.

As filed: BLUEBIRD STRATEGIES for MYOTONIC.

All filings by Bluebird Strategies · Everything Myotonic has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 21, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Funding for myotonic dystrophy research as part of the FY26 Congressionally Directed Medical Research Program

Budget/Appropriations

Myotonic dystrophy biomedical research funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.